{"task_id": "af33b83342c72d74", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 106/464)", "text": "ETERIZATION\nAcute Respiratory Distress Syndrome\n93\n\n--- Page 115 ---\nDIAGNOSTIC AND PROGNOSTIC ISSUES\nACUTE LUNG INJURY\nmilder form of ARDS with\nPaO2/FiO2\b300\nPROGNOSIS\nOF\nARDS\noverall\nmortality\nrate\n\u000345%. Mortality increases with additional organ fail\nure (>99% if three system failures)\nMANAGEMENT\nABC\nO2 to keep sat >90%, IV\nMECHANICAL VENTILATION\n\u0004\nLUNG-PROTECTIVE VENTILATION (low tidal volumes to\nminimize ventilation induced lung injury)\nset\ntidal volume \u00034 8 mL/kg, based on ideal body\nweight, maintain plateau pressure \b30 cmH2O\n\u0004 PEEP\nshould be employed to keep FiO2 in pre\nsumed non toxic range (<0.60). Increase PEEP by\nincrements of 3 5 cm (maximum = 15 20 cm) to\nincrease functional residual capacity (may be\nharmful)\n\u0004\nRECRUITMENT\nrecruitment maneuvers may be used\nto keep alveoli open; e.g. 40 cmH2O PEEP for 40 s\nMANAGEMENT (CONT\u2019D)\n\u0004\nPERMISSIVE\nHYPERCAPNIA\ngenerally tolerate pH\n>7.25, may need to run HCO3 infusion to maintain\npH\n\u0004\nSALVAGE/ALTERNATE MODES OF VENTILATION\nAPRV\n(airway pressure release ventilation), HFOV (high\nfrequency oscillatory ventilation)\nMEDICATIONS\nno effective pharmacologic therapy\nfor ARDS. There is limited evidence regarding steroid\nuse for treatment of ARDS and no evidence for pro\nphylaxis. Some clinicians still use in non resolving\ncases (start 7 14 days after onset. Methylprednisolone\n2 mg/kg load, then 2 mg/kg/day from days 1 to 14,\nthen taper by 50%/week to 0.125 mg/kg/day, moni\ntor for infection). Nitric oxide (selectively dilates\npulmonary vessels of ventilated alveoli, improving\nV/Q matching. Reduces pulmonary artery pressures\nand intrapulmonary shunting with an increase in\nPaO2/FiO2)\nTREAT UNDERLYING CAUSE\nVentilation Issues\nMECHANICAL VENTILATION\nINDICATIONS FOR MECHANICAL VENTILATION\n\u0004\nDECREASED COMPLIANCE (stiff lungs)\npulmonary\nfibrosis, pulmonary edema, ARDS\n\u0004\nINCREASED RESISTANCE (narrowed airways, air trap\nping)\nstatus asthmaticus, COPD exacerbations,\nbronchial tumor, excessive secretions\n\u0004\nMECHANICAL\nFAILURE\nspinal\ncord\ninjury,\nGuillain Barre\n\u0004\nLACK OF RESPIRATORY DRIVE\nneurologic disease,\ndrug overdose\nLACK OF RESPIRATORY DRIVE\nhypoxic brain\ninjury, drug overdose\nNON INVASIVE POSITIVE PRESSURE VENTILATION\n(NIPPV)\n\u0004\nCONDITIONS IN WHICH NIPPV IS USED\nCOPD, HF,\nasthma, postoperative respiratory failure, post\nextubation in select situations. If no improvement\nafter 30 min 1 h, should intubate\n\u0004\nINDICATIONS\npH 7.2 7.3, RR >25, use of accessory\nmuscles, and cooperative\n\u0004\nCONTRAINDICATIONS\n# level of consciousness (but\npossible use if due to \" PCO2), respiratory arrest,\nfacial trauma/surgery/burn, airway obstruction,\ncopious secretions, aspiration risk, GI bleeding,\ngastroesophageal surgery, esophageal rupture,\nhemodynamic instability, co existent organ failure,\nmassive obesity, extreme anxiety\nMECHANICAL VENTILATION (CONT\u2019D)\n\u0004\nMASK TYPES\nfull face, nose and mouth, nasal\nonly\n\u0004\nVENTILATORY\nMODES\nCPAP or BIPAP. CPAP is\nmainly used for obstructive sleep apnea; however,\ncan be used in isolated hypoxemia (ventilation\nadequate). BIPAP is used to assist with oxygena\ntion and ventilation\nINVASIVE MECHANICAL VENTILATION\n\u0004\nINDICATIONS\nsevere hypoxemia, acute hypercap\nnia, need for airway protection (GCS \b8), impend\ning airway occlusion, therapeutic hyperventilation.\nIn general, intubation if BIPAP contraindicated or\nfailed, or clinical status severe and likely require\nlonger term ventilation\n\u0004\nTUBES\nendotracheal tubes, tracheostomy tubes\n(see ARTIFICIAL AIRWAYS)\nTERMINOLOGY\n\u0004\nRESISTANCE\nrestriction that inhibits flow of gas in\nairways. May result in increased Ppeak or decreased\nVe\n\u0004\nCOMPLIANCE\nease with which lungs expand.\nNormal \u000350 mL/cmH2O\n\u0004\nTIDAL VOLUME (VT)\namount of air delivered per\nbreath. Normal \u00038 mL/kg (500 mL)\n\u0004\nMINUTE VOLUME (Ve)\namount of air delivered per\nminute. Ve (mL/min)= VT \u0002 RR\n94\nVentilation Issues", "text_length": 3821, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 106/464)", "type": "chunk", "chunk_index": 105, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.389533", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.390754", "status": "complete", "chunks_added": 2}